Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery

Launched by AIN SHAMS UNIVERSITY · Jul 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a specific method called the serratus posterior intercostal plane block, which is used to help manage pain and inflammation in women undergoing breast surgery for cancer. The research aims to see if this technique can effectively control pain after surgery and how it affects certain markers in the body that indicate inflammation.

To participate in the study, women aged 21 to 60 who are scheduled for unilateral (one side) breast surgery under general anesthesia may be eligible. They should have a body mass index (BMI) between 18 and 25 and be in good health (ASA grade I-III). However, some individuals may not qualify, including those with a history of chest surgery, allergies to local anesthetics, or certain medical conditions. If you choose to join the trial, you can expect to receive the study treatment during your surgery and be monitored closely afterward to assess its effectiveness in managing your pain.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adults undergoing unilateral breast surgery under general anesthesia
• • Age 21 to 60 years with body mass index (BMI)=18 to 25 kg/m2
• • American Society of Anesthesiologists (ASA) grade I-III.
• Exclusion Criteria:
• • Patients with Long-time use of analgesic drugs
• • Past history of chest surgery,
• • Allergy to local anesthetics,
• • Systemic infection,
• • Cognitive and language disorders precluding participation,
• • Patients with coagulopathy,anticoagulant users
• • hemodynamic unstable patients
• • Patients with neurology, spinal, psychiatry diseases
• • infection at block site
• • patients refused to participate in the study .